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Quantitative Mass Spectrometry Reveals
Changes in Histone H2B Variants as Cells
Undergo Inorganic Arsenic-Mediated Cellular
Transformation*□S
Matthew Rea‡**, Tingting Jiang§**, Rebekah Eleazer‡, Meredith Eckstein‡,
Alan G. Marshall§¶, and Yvonne N. Fondufe-Mittendorf‡
Exposure to inorganic arsenic, a ubiquitous environmen-
tal toxic metalloid, leads to carcinogenesis. However, the
mechanism is unknown. Several studies have shown that
inorganic arsenic exposure alters specific gene expres-
sion patterns, possibly through alterations in chromatin
structure. While most studies on understanding the mech-
anism of chromatin-mediated gene regulation have fo-
cused on histone post-translational modifications, the
role of histone variants remains largely unknown. Incor-
poration of histone variants alters the functional proper-
ties of chromatin. To understand the global dynamics of
chromatin structure and function in arsenic-mediated
carcinogenesis, analysis of the histone variants incorpo-
rated into the nucleosome and their covalent modifica-
tions is required. Here we report the first global mass
spectrometric analysis of histone H2B variants as cells
undergo arsenic-mediated epithelial to mesenchymal
transition. We used electron capture dissociation-based
top-down tandem mass spectrometry analysis validated
with quantitative reverse transcription real-time polymer-
ase chain reaction to identify changes in the expression
levels of H2B variants in inorganic arsenic-mediated epi-
thelial-mesenchymal transition. We identified changes in
the expression levels of specific histone H2B variants in
two cell types, which are dependent on dose and length of
exposure of inorganic arsenic. In particular, we found
increases in H2B variants H2B1H/1K/1C/1J/1O and
H2B2E/2F, and significant decreases in H2B1N/1D/1B as
cells undergo inorganic arsenic-mediated epithelial-mes-
enchymal transition. The analysis of these histone vari-
ants provides a first step toward an understanding of the
functional significance of the diversity of histone struc-
tures, especially in inorganic arsenic-mediated gene ex-
pression and carcinogenesis. Molecular & Cellular Pro-
teomics 15: 10.1074/mcp.M116.058412, 2411–2422, 2016.
Millions of people worldwide are chronically exposed to
inorganic arsenic (iAs)1, a ubiquitous environmental carcino-
gen, through drinking water and food, with consequences
ranging from acute toxicities to malignant transformations (1,
2). Despite well-known deleterious health effects, the molec-
ular mechanisms in iAs-mediated toxicity and disease are not
fully understood. Several possible mechanisms have been
proposed, including oxidative stress and genotoxic DNA
damage (2–5). Recent evidence suggests that an even less
understood—but equally important—mechanism is toxicity
produced via changes in epigenetic-regulated gene expres-
sion. Proper gene expression requires regulatory proteins to
bind to their target sites on DNA, found in eukaryotic cells as
chromatin, many of which are directed by epigenetic marks.
In eukaryotes, genomic DNA is organized into nucleo-
somes, the fundamental repeating unit of chromatin (6). Each
nucleosome consists of 147 base pairs of DNA wrapping 1.7
turns around a histone octamer comprised of two copies each
of H2A, H2B, H3, and H4 (7–9). The packaging of eukaryotic
genomes with histones to form chromatin is essential for the
necessary condensation and protection of DNA. Changes in
the structure of chromatin are essential for the proper regu-
lation of cellular processes, including gene activation and
silencing, DNA repair, replication and recombination. Altera-
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tions of the chromatin template during these processes can
occur through at least 3 interrelated mechanisms: post-trans-
lational modifications of histones, ATP-dependent chromatin
remodeling, and the incorporation of specialized histone vari-
ants into chromatin. Of these mechanisms, the exchange of
variants into and out of chromatin is the least understood or
studied. It is now known that the exchange of conventional
histones for variant histones has distinct and profound con-
sequences within the cell (10, 11).
The intricate mechanisms of regulation that involve chro-
matin are largely based on the enormous complexity built into
its structure. A number of studies have demonstrated that iAs
exposure induces global and gene-specific post-translational
histone modifications such as reduction of acetylation in his-
tone H3 and H4: loss of H4Lys16ac, increases in H3Lys14ac,
H3Lys4me3, changes in methylation: increases in H3Lys4me2,
H3Lys4me3, loss of H3Lys27me3, loss or gain of H3Lys9me2,
increases in H3Ser10 and H2AX phosphorylation, and de-
creases in H2B ubiquitination (12–26).
Although histone post-translational modifications are
clearly an important source of complexity, each of the canon-
ical histones has multiple variants that can be incorporated
into various chromatin loci at different times of the cell cycle
(27). These histone variants can be divided into two groups
based on whether their expression is regulated during repli-
cation—replication-dependent and replication-independent.
Histone variants are found in distinct gene clusters within the
human genome (11, 28). Interestingly, although they differ in
their primary sequences, some of these encode similar pro-
teins, whereas others do not (28, 29). For example, 22 genes
code for replication-dependent histone H2B variants and they
produce 16 distinct polypeptides.
The function and physiological roles of some histone vari-
ants have been well studied. For example, the H2A replica-
tion-independent histone variant H2A.X is phosphorylated
near the sites of DNA double-strand breaks, facilitating the
assembly of DNA repair factors (30). Another replication-in-
dependent variant, H2A.Z, is known to compact chromatin
and poise genes for activation (reviewed in (31)). Two well-
studied H3 replication-independent variants are H3.3, best
known for its association with active transcription, and
CenH3, found at the centromere and involved in kinetocore
assembly (32). Expression of these replication-independent
variants is not limited to any specific time during the cell cycle.
In contrast, replication-dependent variants are expressed
solely during S-phase of the cell cycle (33–35). All five classes
of histones (H1, H2A, H2B, H3, and H4) have replication-de-
pendent variants. The expression, integration and functional
roles of most histone variants, especially the replication-de-
pendent ones, have not been identified (33–35). Of the 16
unique H2B variants, 13 are somatic and 3 are testis-specific
(H2BFWT, H2B1A, and H2BFM). These testis-specific vari-
ants have been characterized and have very different protein
sequences (36–38). We hypothesize that alterations in the
expression and incorporation of these variants depends on
developmental and environmental cues.
How do Histone Variants Get Incorporated?—Due to the
weaker contacts between H2A/H2B dimers and DNA, the
DNA at the entry/exit sites of the nucleosome is more prone to
transiently unwrap (39). This allows for higher turnover rates
for histones H2A and H2B than for H3 and H4 (40, 41). In this
study, we focused on the variants of histone H2B, in partic-
ular, as their expression changes during iAs-mediated epithe-
lial-to-mesenchymal transition (EMT) (42). To date, no func-
tional role for the H2B variants has been elucidated (35, 43).
However, the clinical importance of histone variants is high-
lighted by recent reports that identified alterations in specific
histone H2B variants in specific cancer cell types, suggesting
cancer or tissue-specific H2B variant regulation (38). In fact,
there are 22 genes encoding the different H2B variants within
the human genome spread across the three major histone
gene clusters. Fifteen of the H2B variants are found within the
HIST1 gene cluster, encoding 11 unique variants, five are
located on the HIST2 cluster and the last two are located in
the HIST3 cluster (28, 29).
Histone H2B variants are highly sequence-conserved, dif-
fering only by a few amino acids (supplemental Fig. S1A). This
high degree of sequence identity makes the H2B variants
challenging to study with standard protein techniques that
would require the use of variant-specific antibodies. However,
MS can readily resolve them because of the changes in mass
from the differences in amino acids found in the variants (35,
38, 43). Thus, in this study, we used top-down ultrahigh
resolution Fourier transform ion cyclotron resonance (FT-ICR)
tandem mass spectrometry (MS/MS) to quantify the relative
abundance of histone H2B variants in cells undergoing iAs-
mediated EMT. By comparing the histone H2B variant profiles
between normal cells and iAs-transformed (iAs-T) cells, we
identified significant changes in the levels of expression of
specific histone H2B variants in iAs-T cells. Our studies high-
light the enormous heterogeneity of histone variants present
in human cells and indicate the importance of quantifying the
histone proteome as cells go through differentiation to under-
stand the impact of chromatin structure on carcinogenesis.
EXPERIMENTAL PROCEDURES
BEAS-2B and HeLa Growth Conditions and Cell Transformation
Through Sodium Arsenite Exposure—BEAS-2B and HeLa cells were
grown in Dulbecco’s modified Eagle medium (Sigma-Aldrich, St.
Louis, MO), supplemented with 10% fetal bovine serum (Sigma-
Aldrich), 1% MEM nonessential amino acids (Sigma-Aldrich) and 1%
penicillin-streptomycin (Sigma-Aldrich). Cells were grown to 80%
confluency in a humidified chamber at 37 °C, 5% CO2. Cells were
transformed (iAs-T) with sodium arsenite (Sigma-Aldrich) as previ-
ously described (42). Thus, cells were continuously treated with a low
dose of iAs, either 0.5 M or 1 M, until transformation (about 36
days). For reversed cells (iAs-Rev), at 36 days of exposure to iAs,
exposure was stopped and cells continued to grow under non-iAs
conditions. Time matched control cells were treated with water (non-
treated or NT cells).
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Preparation of Nuclei and Extraction of Histones—Cells were re-
leased from plates by trypsinization, and pelleted by centrifugation at
1000  g. Cell pellets were washed twice with phosphate buffered
saline (PBS), and then resuspended in standard nuclei isolation buffer
(15 mM Tris-HCl, pH 7.5, 60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 1 mM
CaCl2, 250 mM sucrose, and 0.3% Nonidet P-40. 1 mM dithiothreitol,
10 nM microcystin, 0.5 mM 4-(2-aminoethyl) benzenesulfonyl fluoride,
and 10 mM sodium butyrate were added as inhibitors). After incuba-
tion on ice for 5 min at 4 °C, pellets were centrifuged at 600  g for
5 min to obtain nuclei. The isolated nuclei were resuspended in 0.2 M
H2SO4 at a ratio of 10:1 for 2 h while rotating at 4 °C. After centri-
fugation at 3400  g, supernatant was precipitated with 25% (final
concentration) of trichloroacetic acid on ice for 45 min. After centri-
fugation, the recovered histones were washed with 0.1% hydrochloric
acid in acetone, with subsequent acetone washes. Thereafter, histone
pellets were air-dried overnight at room temperature for high-per-
formance liquid chromatography (HPLC) purification.
HPLC Separation of Histones—Extracted histones were further
purified by reversed-phase (RP) HPLC on a Dionex UltiMate 3000 
2 Dual Analytical system (Thermo Scientific, Waltham, MA) with a
4.6  250 mm, 5 m, 300 Å pore size C18 column (218TP52, GRACE/
Vydac, Columbia, Maryland). Individual histones were eluted from the
column by applying a linear gradient of acetonitrile (30–60% B with a
0.3% B increase over 105 min; solvent A: 0.2% trifluoroacetic acid in
5% acetonitrile; solvent B: 0.188% trifluoroacetic acid in 95% aceto-
nitrile. The flow rate was set at 0.8 ml/min. All histone fractions were
collected with a fraction collector and dried under vacuum centrifu-
gation (model SPD121P; Thermo Scientific).
9.4 T FT-ICR MS—Prepared histone samples were dissolved in
50% acetonitrile (H2O/CH3CN) (50/50) with 1.0% formic acid to reach
a final concentration of 1.0 M and introduced into a custom-built 9.4
Tesla FT-ICR mass spectrometer via positive electrospray ionization
(44). Both precursor and product ion spectra were acquired by direct
infusion at the flow rate of 0.35 l/min. Precursor ions of interest were
first selected by a quadrupole mass filter and further isolated by
Stored Waveform Inverse Fourier Transform (SWIFT) ejection in the
ICR cell (45). Electron capture dissociation (ECD) experiments were
performed at a potential of 5 V dc on an accelerating grid and 2.5 V
on the cathode during electron ejection. Prior to ECD analysis, a 50
ms delay was added to compensate for ion magnetron motion in the
ICR cell (46). 500–1000 time-domain transients were averaged to
improve signal to noise ratio for each product ion spectrum. The
spectrometer was controlled by a modular ICR data acquisition sta-
tion (Predator) (47). Each time-domain ICR signal is Hanning apo-
dized, zero-filled once, fast Fourier transformed to magnitude mode,
and converted to a mass-to-charge ratio spectrum by a two-term
calibration equation (48).
qRT-PCR—RNA was isolated from HeLa and BEAS-2B cell lines,
1  107 cells, by use of the RNeasy MiniKit (Qiagen, Hilden, Ger-
many). One microgram of RNA was used in a reverse transcriptase
reaction with iScript Reverse Transcriptase (Bio-Rad, Hercules, CA
#1708891) to prepare cDNA. 25 ng of the cDNA was used in qRT-
PCR reactions. The protocol used for H2B variants was as follows: (1)
94 °C 5 min, (2) 94 °C 30 s, (3) 52 °C 30 s, (4) 72 °C 45 s, 2–4 repeated
40 cycles, 72 °C 10 min. HIST2H2BE and HIST2H2BF used the fol-
lowing protocol: (1) 94 °C 5 min, (2) 94 °C 30 s, (3) 60 °C 30 s, (4)
72 °C 45 s, 2–4 repeated 40 cycles, 72 °C 10 min. H2B variant
primers were used as described in a previous study (49). EMT mark-
ers were amplified according to the following protocol: (1) 94 °C 5
min, (2) 94 °C 30 s, (3) 56 °C 45 s, (4) 72 °C 45 s, 2–4 repeated
40 cycles, 72 °C 10 min. Primers for the housekeeping gene
(GAPDH) and primers used for EMT markers were made for this
study by use of PrimerBank (50–52) (http://pga.mgh.harvard.edu/
primerbank) and are available in supplemental Table S1. qRT-PCR
data was analyzed by the 2Ct method, and Student’s t-tests were
performed for significance.
Western Blot Analysis—Total protein was extracted from 107 HeLa
or BEAS-2B cells. Cells were sonicated for 30 s followed by a 30 s off
period for a total of 12 cycles (Diagenode Biodisruptor 300), and
centrifuged at 12,800  g at 4 °C for 15 min to pellet cellular debris.
Total protein concentration was measured by use of a BCA kit (Ther-
moFisher #23221) and 25 ng of total protein were loaded into each
lane of a 10% SDS-PAGE gel. Gels were run at 120 V until the loading
dye reached the end of the gel and then transferred to polyvinylidene
fluoride membranes (PVDF) at 65 V for 90 min on ice. Membranes
were blocked with 5% Milk  phosphate buffered saline with Tween
20 (PBST) and incubated with primary antibodies (Cell Signaling
Technologies, Danvers, MA #9782, EMT Antibody Sampler Kit) (in
0.5% Milk  PBST) overnight at 4 °C. A secondary antibody (-Rabbit
or -Mouse) was applied the next day and developed by use of ECF
(GE-Typhoon FLA9500).
RESULTS
Transformation of Cells by Low-dose Chronic Exposure to
iAs—Chronic low-dose exposure to iAs is known to cause
cells to undergo EMT (42, 53, 54). As cells go through EMT,
changes in cell morphology and expression patterns of EMT
markers occur. In this study, we used a similar procedure as
previously shown to induce EMT, by exposing cells to low-
dose iAs for 5 weeks (42). We used two types of cells, HeLa
and BEAS-2B cells, and monitored changes in growth and
morphology. After 5 weeks of exposure to these low doses of
iAs, BEAS-2B cells became elongated and spindle-shaped,
indicating EMT transformation (Fig. 1A). HeLa cells showed
similar changes (data not shown). We confirmed EMT trans-
formation in two ways: (1) at the protein level, using Western
blot analyses, to measure the protein levels of known EMT
markers (Fig. 1B); and (2) at the transcript level, quantitative
reverse transcription real-time PCR (qRT-PCR) was used to
measure the transcript levels of these known EMT markers
(Fig. 1C). Previously, we have shown that iAs-mediated EMT
correlated with alterations in chromatin structure and epig-
enomic changes. These studies showed broad chromatin
structural changes (42). However, in the current study, we
attempted to better define the details of these changes in
chromatin structure. Thus, after confirming transformation, we
asked whether there are differences in histone H2B variants in
iAs-T cells compared with normal cells.
Top-down MS/MS Analysis of Histone H2B—We purified
histone H2B from acid-extracted histones by C18 reversed-
phase chromatography (Fig. 2A). The purified H2B was in-
jected directly into the mass spectrometer (see Experimental
Procedures) and the collected spectra were used to deter-
mine the masses of the H2B variants. Five major peaks were
observed in the broadband spectrum of histone H2B from NT
and iAs-T cells as shown in Fig. 2B. The molecular mass of
each peak was determined by deconvolution of multiply
charged ion species and then compared with the calculated
masses of all histone H2B sequence variants (Table I). All raw
ECD product ion mass spectra were phase-corrected and
analyzed by our in-house software in a variant-specific man-
H2B Variants Expression During iAs-mediated EMT
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ner to determine each proteoform (55, 56). Briefly, a library of
all known H2B sequence variants from Uniprot was imported
into our software for identification and characterization. The
software determines the isotopic distribution of all potential
fragment ions of all variants by combining possible post-
translational modifications and then checking for the pres-
ence of each possible fragment ion of all variants. All possible
proteoforms are assigned and ranked by an objective func-
tion, which is generated based on the sum of peak heights of
all assigned peaks within a given mass error tolerance of 10
ppm for every possible proteoform. Usually, a higher score
indicates a better match, but some of the top assignments are
not valid based on the intact protein mass obtained from the
broadband spectrum. We manually filter out these unreason-
able assignments. For example, H2B1C sometimes has a
higher score than H2B1H for the first peak in Fig. 2 because
of the highly similar sequences of H2B1C and H2B1H/1K
(Table I). However, the intact experimental mass for the first
peak does not agree with the calculated H2B1C mass; thus,
producing a false positive result, which we eliminate. ProSight
Lite was conducted at the same time to validate our identifi-
cations (44).
Because H2B variants have highly similar sequences (Table
I and supplemental Fig. S1), some of them have the same or
very similar molecular masses (2 Da difference), which are
unresolved by quadrupole MS precursor ion isolation. How-
ever, we were able to perform ECD experiments to differen-
tiate them based on their specific c and z fragment ions. For
example, H2B2E and H2B2F are structural isomers (i.e. they
share the same molecular mass) differing by only 3 amino
acids at sites 2, 21 and 39, whereas the nominal mass of
H2B1N is 2 Da greater than H2B2E with variations in 2 amino
acids at sites 4 and 39 (Table I). These similar molecular
weights make them difficult to resolve by quadrupole MS (Fig.
2A, 2B). Thus, the isotopic distribution of the overlapping
isotope distributions was isolated by SWIFT, as shown in Fig.
2B, and then subjected to ECD fragmentation. Because
H2B1N, H2B2E, and H2B2F differ by amino acids 2, 4, 21,
and 39, and the rest of the sequences are exactly the same we
can distinguish them by their critical fragment ions, c2-c38
FIG. 1. Chronic low-dose exposure to iAs
causes cells to undergo EMT. A, Morphology
changes seen in iAs-transformed BEAS-2B cells.
BEAS-2B cells become elongated and spindle-
shaped with 0.5 M iAs treatment. B, Western blot
analyses of EMT markers showing changes in the
EMT markers. For instance, -Catenin levels de-
crease and Slug levels increase in iAs transformed
cells. C, qRT-PCR confirmation of iAs-induced EMT
markers in HeLa (top) and BEAS-2B (bottom). qRT-
PCR confirms the changes in expression of EMT
markers in iAs-transformed cells. Error bars repre-
sent standard deviation (S.D.) from three biological
replicates, each containing three technical repli-
cates. Asterisks denote p values  0.05 as deter-
mined by Student’s t test.
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and z105-z123. From the ECD product ion mass spectra, we
identified 19 critical c ions for H2B1N (Fig. 3; supplemental
Fig. S2), 34 for H2B2E (Fig. 3; supplemental Fig. S3) and 26 for
H2B2F (Fig. 3, supplemental Fig. S4), which confirmed the
co-existence of these three sequence variants within the initial
peak. For quantification, we calculate their fragment ion rela-
tive ratios based on the common ions from those critical c
ions of all three variants. The same principle applies for
H2B1H/1K and H2B1C/1J/1O (supplemental Fig. S5). Of all
known variants, we identified 10 with differential expression
in one top-down experiment of which eight are located in
the HIST1 gene cluster HIST1H2BH (H2B1H), HIST1H2BK
(H2B1K), HIST1H2BC (H2B1C), HIST1H2BJ (H2B1J),
HIST1H2BO (H2B1O), HIST1H2BN (H2B1N), HIST1H2BD
(H2B1D), and HIST1H2BB (H2B1B) and two are located in the
HIST2 gene cluster HIST2H2BE (H2B2E) and HIST2H2BF
(H2B2F). Further, these 10 variants were quantified according
to their normalized abundance in the same broadband mass
spectrum and their fragment ion relative abundance ratios (35,
57). No post-translational modifications were observed for
any of the sequence variants in either HeLa or BEAS-2B cell
lines.
Mass Spectrometry Profiling H2B Variants in iAs-mediated
EMT Cells—Previous studies have demonstrated variation in
the expression of the mRNA of different H2B variants across
cancer cell lines (49, 58). This suggests that there may be
different abundances of H2B variant proteins between cell
lines and possibly cell-type-specific functions for the different
H2B variants. We therefore asked whether there are variations
in expression of these variants as cells go through iAs-medi-
FIG. 2. Electron Capture Dissociation top-down MS/MS
of H2B isoforms. A, Off-line reversed-phase liquid chromato-
gram for histones. B, Representative mass spectrum of histone
H2B sequence variant isotopic distributions for charge state,
Z  19. Precursor m/z 726.75 ions were isolated by SWIFT and
fragmented with ECD.
TABLE I
Comparison of H2B variants. Experimental and calculated neutral masses of H2B variants that showed changes in expression in iAs-induced
EMT transformed cells. Also shown are the amino acids, accession number of the variants, and their positions that differ between the various
variants
Sequence
variant
Accession
number
Neutral mass (Da) Amino acid positions
Experimental Calculated 2 4 18 21 39 124
H2B1H Q93079 13758.72 13760.92 DPA V A V S
H2B1K O60814 13758.72 13758.95 EPA V A V A
H2B1C P62807 13774.87 13774.95 EPA V A V S
H2B1J P06899 13774.87 13772.97 EPA V A I A
H2B1O P23527 13774.87 13774.95 DPA V A I S
H2B1N Q99877 13789.12 13790.95 EPS V A V S
H2B2E Q16778 13789.12 13788.97 EPA V A I S
H2B2F Q5QNW6 13789.12 13788.97 DPA V V V S
H2B1D P58876 13804.89 13804.97 EPT I A V S
H2B1B P33778 13819.52 13819.00 EPS I A I S
H2B Variants Expression During iAs-mediated EMT
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ated EMT. Cells were collected at days 4, 8, and 16 during the
process of iAs-mediated EMT to examine variant expression.
Histones were extracted and subjected to MS/MS. Of the H2B
variants that were identified through mass spectrometry, ten
were found to have expression level changes during the iAs-
mediated EMT compared with NT HeLa cells. Seven of the
H2B variants were up-regulated (H2B1H, H2B1K, H2B1C,
H2B1J, H2B1O, H2B2E, H2B2F) and three were downregu-
lated (H2B1N, H2B1D, H2B1B) (Fig. 4A). We also transformed
these cells with two different concentrations of iAs (0.5 M
and 1 M). For the majority of the histone variants, there was
no difference in expression between the iAs doses. We did
observe changes for three variants (H2B1C, H2B2F, and
H2B1B) with the 0.5 M treatment having an enhanced effect
compared with the 1 M treatment of iAs (Fig. 4A). However,
this might not be biologically significant because in both
doses there is a significant change in expression level com-
pared with the nontreated cells. Whether these slight differ-
ences in the 0.5 M compared with the 1 M is biologically
significant remains to be explored.
Next we asked if the observed changes in the levels of
these variants were cell-type specific. To answer this ques-
tion, we extracted histones from iAs-T BEAS-2B cells and the
abundance of the H2B variants was investigated through
mass spectrometry (Fig. 2). The expression levels of the H2B
variants in BEAS-2B cells followed the same patterns of up- or
down-regulation seen previously in the iAs-T HeLa cells (Fig.
4A, supplemental Fig. S6). On the other hand some of the
changes seen were not as drastic as in the iAs-T HeLa cells
(Fig. 4B). To determine if overall levels of histones were
changing in cells exposed to iAs, Western blot analysis for
total histone H2B and total histone H3 were performed. As
shown (Fig. 4C), there is no difference in the expression of
H2B or H3 proteins in nontreated and iAs transformed cells. In
addition, three of the histone variants in the BEAS-2B iAs-T
cells showed an expression pattern that differed from the
HeLa iAs-T cell expression pattern. H2B1J, H2B1O, and
H2B2E in HeLa cells showed an overall up-regulation com-
pared with NT cells. However, in the BEAS-2B transformed
cells, there is a decrease in the abundance of these variants
compared with the NT cells (Fig. 4, supplemental Fig. S6).
These differences could be because of a couple of possibili-
ties: (1) The process of EMT involves a number of stages (59,
60). Although HeLa cells are carcinogenic, they can still, under
specific conditions, undergo further EMT (Fig. 1) (61, 62). On
the other hand, BEAS-2B cells are considered normal and
thus the process of transformation will involve many more
steps than HeLa cells. (2) The differences we see could be
cell-type specific. In summary, the differences in the H2B
variant levels in the iAs-mediated EMT suggest that these
variants are being expressed and regulated for specific pur-
poses in the cells, especially those that have undergone iAs-
mediated EMT.
Time-dependent Mass Spectrometry Profiling in H2B Vari-
ants as Cells Go Through iAs-mediated EMT—We next asked
if there were changes in the abundance of the histone variants
as cells go through iAs-mediated transformation. H2B vari-
ants levels were analyzed at days 4, 8, and 16 of iAs-treat-
ment. Six variants exhibited significant differences in their
levels throughout the time course as cells went through iAs-
mediated EMT (supplemental Fig. S7). Compared with time-
matched controls (NT), the abundance of H2B1C increased at
each day of exposure. Likewise, H2B1K levels increased with
the days of iAs exposure (Fig. 5). On the other hand, H2B1D
abundance overall decreased across all three time points of
exposure, but interestingly on day 8 the levels in iAs-treated
cells increased to near those of NT cells, and by day 16 they
decreased to well below the levels in NT cells (Fig. 5). H2B1B
abundance in iAs-treated cells decreased similarly throughout
the exposure times (Fig. 5). In summary, the changes in pro-
tein levels seen in H2B1K and H2B1C suggest that they are
actively being added into chromatin as the cells undergo
FIG. 3. Upper left. ECD product ion
spectrum for precursor (H2B1N/2E/
2F) m/z 726. 75 ions. Upper right and
bottom. ECD fragmentation maps gen-
erated by our custom software. When
peptides are dissociated, c ions contain
the charge at the N terminus, whereas
z ions contain the charge at the C
terminus.
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iAs-mediated EMT. The changes in abundance seen in
H2B1D and H2B1B suggest that as cells undergo the
changes in iAs-mediated EMT, they are actively excluded
from chromatin. As there was little difference seen between
the cells exposed to the two concentrations, we used only the
1.0 M concentration for HeLa cells from this point forward
(iAs-T). The directionality in the changes in the abundance of
these histone variants are consistent with cells treated for 5
weeks (iAs-T cells - Fig. 4) and could indicate that these
changes in the abundance of histone variants occur early and
drive the gene expression patterns in iAs-EMT.
mRNA Profiling of the H2B Variants by qRT-PCR—As there
were changes in protein levels of the H2B variants seen in
the MS data, we were interested to see if these changes were
correlated with changes in mRNA expression. To investigate
the gene expression levels of the H2B variants, we used
qRT-PCR on technical as well as biological replicates. RNA
was extracted from the same cell population used in the mass
spectrometry analyses, reverse transcribed and used for qRT-
PCR. In both cell types, the overall gene expression patterns
were similar to those of the mass spectrometry data (protein
levels). In HeLa cells (Fig. 6A), the expression levels of 7 out of
the 10 H2B variants (70%) were confirmed with qRT-PCR.
The expression levels of all ten of the H2B variants observed
in mass spectrometry data were confirmed for the BEAS-2B
cells (Fig. 6B).
Effects of Removal of iAs in Transformed Cells—Once cells
were transformed and changes to morphology and EMT were
measured, we asked what would happen to EMT and histone
expression when the iAs exposure is removed (iAs-Rev). We
have previously shown that cell morphology and expression
of certain genes reverted to normal levels after removal of iAs
from iAs-T cells (42). We thus carried out similar studies and
confirmed in these iAs-Rev cells that the morphology of the
cells reverted toward NT cells, though not completely (not
shown). Furthermore, we also had previously reported that
some gene expression patterns reverted completely whereas
others did not. We proposed that the gene expression pat-
terns that did not revert completely were responsible for the
sustenance of the oncogenic potential of these cells (42). In
this study, we also observed that in iAs-Rev cells, the expres-
sion levels of some EMT markers did not completely revert to
nontreated levels, substantiating our initial observation. In
Western blot analysis for EMT markers, we show that in
HeLa-iAs-Rev cells, the expression levels of some EMT mark-
ers showed intermediate protein levels, most notably in Clau-
din-3 and Slug (Fig. 7A). When qRT-PCR was performed to
investigate gene expression of these EMT markers, we saw
mixed levels in the HeLa RT. For instance, the data for
-Catenin, E-cadherin, and ZO-1 show that these genes are
expressed at similar levels as the iAs-T HeLa cells. N-cadherin
shows an increase in expression in the transformed cells;
however in the iAs-Rev cells, its expression was higher. Clau-
din-1, Slug, and Vimentin, as well as Snail and ZEB1, all show
the opposite gene expression patterns as the iAs-T cells (Fig.
7B). This opposite expression pattern would suggest the cells
are reverting to a normal HeLa phenotype, albeit incompletely.
We then asked whether in iAs-Rev cells, the alterations in the
levels of histone variants were also observable. We carried out
qRT-PCR to measure the expression of the above 10 histone
variants whose expression was altered in iAs-T cells. Here
too, we observed some of these variants reverting to NT
levels, whereas others stayed altered. We observed that the
expression levels for H2B1N, H2B1B, and H2B1D were de-
creased similarly in iAs-Rev cells as in iAs-T cells (Fig. 7C). On
the other hand, the expression levels for both H2B1H and
H2B1O in iAs-Rev cells were at levels that were increased
above and beyond the iAs-T cells. H2B1K, H2B1C, H2B1J,
H2B2F, and H2B2E all show a decrease in iAs-Rev expression
of the variant compared with levels in the iAs-T cells (Fig. 7C).
FIG. 4. Mass spectrometry profiling of H2B variants in NT and
iAs-T cells. A, Profiles of H2B variants in HeLa cells show differential
abundance of 10 histone H2B variants in iAs-transformed cells com-
pared with time-matched NT cells, after 16 days of treatment. Addi-
tionally, there were no major changes in the expression levels in cells
transformed with 0.5 M and 1 M iAs. B, Changes in the abundance
of these variants were confirmed in BEAS-2B cells. Although most of
the variants show patterns similar to iAs-T HeLa cells, H2B1J,
H2B1O, and H2B2E, show different patterns of expression in the
iAs-T BEAS-2B cells. C, Western blots of total histones H2AB and H3
show equal expression in treated and nontreated cells. Equal
amounts of nuclear protein (25 ng) were loaded onto a 15% SDS-
PAGE gel and blotted for H2B or H3. Error bars represent standard
deviation from three technical replicates. Biological replicates in HeLa
and BEAS-2B cells show a similar trend (supplemental Fig. 7). Aster-
isks denote p values  0.05 as determined by Student’s t test.
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Thus, these five variants seem to be reverting to the levels in
HeLa NT cells.
Although these cells had the iAs removed, some of the key
EMT genes remained altered, possibly allowing the cells to
remain tumorigenic (42). It is possible that some histone vari-
ants, just like with those genes that did not revert completely,
could be driving the metastatic potential of these cells, even
when they are no longer exposed to iAs. One possibility is that
the incorporation of these histone variants allows for an epi-
genetic program that drives specific gene expression patterns
with carcinogenic potential. More studies will be needed to
elucidate this hypothesis.
DISCUSSION
Epigenetic modifications in response to environmental dis-
ruptors include changes in histone modifications, DNA meth-
ylation, ATP-dependent chromatin remodeling, and incorpo-
ration of histone variants (63). While so many studies have
focused on other epigenetic factors, the impact of histone
variants in this process has remained largely understudied. In
this study, we present the first analyses of its kind, determin-
ing the changes in the levels of histone H2B variants in iAs-
mediated cancer pathogenesis. Using top-down MS/MS, we
identified 10 histone H2B variants that showed differential
expression in iAs-T HeLa cells (Fig. 4A). Most striking were the
large differences in the levels of four H2B variants: down-
regulation of H2B1B and H2B1D and up-regulation for H2B1C
FIG. 6. Validation of H2B changes with qRT-PCR. A, qRT-PCR in
HeLa cells validated the expression patterns of 7 of the 10 H2B
variants investigated through MS. B, qRT-PCR in BEAS-2B cells
validates the expression patterns of all 10 H2B variants. Error bars
represent S.D. from three biological replicates, each containing three
technical replicates. *, p value  0.05, determined by Student’s t test.
FIG. 5. Time-dependent changes in H2B variants as cells
undergo iAs-mediated EMT. The abundance of histone H2B
variants was monitored at different times during the iAs-trans-
formation process. Changes by day (Top-4 days, Middle-8
days, Bottom-16 days) of the H2B variants showed that the
most overall up-regulated histone H2B variants were H2B1K
and H2B1C, whereas the most downregulated variants were
H2B1D and H2B1B. Shown next to the graphs are the obtained
ECD spectra for these four variants. The full extent of the
changes in the relative abundance of the 10 observed H2B
variants changes and a consequence of exposure time (days of
exposure) are shown in supplemental Fig. 6 and ECD fragmen-
tation maps in supplemental Fig. 5. Untreated cells are from
the same days as the treated groups. Error bars represent S.D.
from three technical replicate experiments. *, p value  0.05 as
determined by Student’s t test.
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and H2B1K (Figs. 5 and 6). We confirmed alterations in H2B
variants in a second iAs-T cell line, the lung epithelial
BEAS-2B cells, suggesting that turnover of these variants is
important in iAs-dependent EMT pathology and not cell-type
dependent (Fig. 4B). Lastly, we validated the changes in gene
expression of these variants using qRT-PCR (Fig. 6). These
studies indicate that incorporation of variants into chromatin
might be responsible for the specific epigenetic reprogram-
ming in iAs-mediated EMT pathology.
Several recent reviews have highlighted the epigenetic role
of histone variants (64–67) and have shown the importance of
these variants in the progression of cancer to different stages
(68–73). Underscoring that importance, the expression of
H2B histone variants is cell-type specific, differentiation
stage-dependent as well as cancer-stage and type depend-
ent (38). However, the study of these variants has remained
difficult largely because they differ by very few amino acids
(Table I; supplemental Fig. S1), making variant-specific anti-
bodies virtually impossible to develop. However, the use of
top-down MS/MS has proven to be an invaluable tool to study
such closely related histone variants (38). This type of mass
spectrometry characterizes the histone proteome in an unbi-
ased approach, providing a sequence that does not rely on
the existence of modification-specific antibodies. The top-
down method, which allows for whole protein sequencing, is
a great tool for distinguishing histone variants (74).
Importance of Histone Variants in Gene Regulation—H2B
variants are involved in the indexing of the genome, in this
way establishing different regulated regions that can be acti-
vated or repressed for transcription. As such, histone variants
may confer a new level of gene expression regulation, impor-
tant for cell-type or tissue-specificity and adaptation to spe-
cific cellular events. The understanding of the various histone
variants and their incorporation in each toxin-associated dis-
ease may be a useful tool for identifying diseases and may
unveil their pathogenesis because incorporation of histone
variants can change the functionality of these proteins.
Why Does the Turnover of Histone H2B Matter?—The het-
erodimer of histone H2A-H2B forms a core component of the
nucleosome. Structurally, the dissociation of this H2A-H2B
dimer from the nucleosome core results in the exposure of a
region around the DNA pseudo-dyad axis of symmetry in the
nucleosome (39–41). This exposure, with consequences in
factor accessibility to the DNA, has functional consequences
in gene regulation. This important observation was proposed
to explain the subnucleosomal structures observed upon
transcriptional activation of the heat-shock inducible HSP82
gene in yeast (75). Interestingly, a recent genome-wide anal-
ysis in budding yeast has provided further support to the idea
of a widespread presence of these (and other) subnucleo-
somal particles (76). Thus, the association of the histone
H2A-H2B dimer with the nucleosome, including its many vari-
ants, plays a critical role in nucleosome dynamics (77) and
functional adaptability (78). However, the structural role of the
different H2B variants contributing to this dynamic has re-
sulted in a new epigenetic paradigm.
In humans, there are 16 reported H2B variants (13 somatic
and 3 testis-specific), adding to the complexity of this para-
digm. It will be of interest to understand when and where
these variants are located genome-wide and the functional
consequences of this incorporation. In these studies, we did
not observe any post-translational modifications on the H2B
variants and it was not surprising, as relatively very few post-
translational modifications have been reported for histone
H2B compared with other core histones.
H2B Variants During Differentiation and Dedifferentia-
tion—In organisms, little is known about the distribution of
H2B variants during processes that involve alterations in chro-
matin function, such as differentiation and dedifferentiation. In
this study, we evaluated the ratio of each histone H2B variant
FIG. 7. Effects with the removal of iAs-treatment after transfor-
mation (iAs-rev cells). A, Western blot analyses of EMT markers.
Claudin-3 and Slug in iAs-rev cells show an intermediate level of
expression, whereas others such as -Catenin and Vimentin revert to
near NT levels. B, qRT-PCR for EMT markers. qRT-PCR for EMT
markers in iAs-Rev cells mostly show changes in expression opposite
of the iAs-T cells. C, qRT-PCR of the H2B variants. qRT-PCR for H2B
variants in iAs-Rev cells mostly show changes in expression reverting
to near NT cells. Error bars represent S.D. from three biological
replicates, each containing three technical replicates. *, p  0.05
compared with NT; †, p  0.05 between iAs-T and iAs-Rev.
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as cells go through dedifferentiation after arsenic removal
(iAs-Rev), in order to define possible alterations either during
iAs-EMT (differentiation) or iAs-Rev (dedifferentiation). We
propose that the alterations in these histone variant ratios are
correlated with iAs-mediated EMT (differentiation) and the
physiological status of the cell. Indeed, we show that when
iAs is removed from iAs-T cells, some of the induced epige-
netic events, gene expression and chromatin structural
changes reverted to pre-iAs exposure levels, albeit incom-
pletely. We also show that some of the histone variants
revert to pre-iAs exposure, whereas others stay altered (Fig.
7). It is possible that the continuous incorporation of a
subset of histone variants sustain the pathogenic state in
iAs-Rev cells. However, further studies will be needed to
test that hypothesis.
Lastly, although the functional analysis of these distinct
replication-dependent H2B variants is only beginning, the
observation that their abundances are altered in iAs-mediated
EMT process supports the intriguing possibility that they may
perpetuate specific expression patterns. Additionally, identi-
fication of the molecular make-up of these histone variants
and their target genes will be needed to determine whether
the various forms of histone H2B play a functional role in
disease progression. However, the high amount of sequence
identity among the histone variants provides challenges for
studies aimed at understanding the physiological roles of the
H2B variants in iAs-mediated transformation.
The changes in expression that are induced by these his-
tone variants appear to be important to the changes that are
seen in the iAs-mediated EMT. These H2B variants, even
though located within gene clusters, have individual promoter
regions (37). Our results indicate that the patterns of histones
H2B variants found in iAs-mediated EMT models are highly
dynamic. For example, the pattern of H2B variants observed
in HeLa iAs-T cells was very similar to BEAS-2B lung epithelial
cells, suggesting perhaps that the same mechanism is used
by iAs-signaling resulting in the deposition of these specific
histone variants. Moreover, the possibility exists that there
may be iAs-mediated EMT specific variations in the patterns
of H2B species. These changes in the expression patterns of
the H2B variants may be responsible for the chromatin rear-
rangements that occur for iAs-mediated pathogenesis. Re-
cent studies have highlighted the role of iAs on the expression
of histones. Arsenic exposure induced the polyadenylation of
the canonical histone mRNAs, which otherwise do not have
this tail (79). Implicated as a possible mechanism is the de-
pletion of the stem-loop binding protein by iAs. These histone
variants, in our studies, all have the polyadenylated tails, thus
protected from degradation. In fact expressing of canonical
histone proteins with polyadenyalted tails, recapitulated the
iAs-transformation state. These studies and ours suggest that
the dynamic control of histone proteins is important and could
play a role in arsenic-induced transformation. Further studies
will be needed to test this idea.
In conclusion, we identified 10 H2B variants that showed
differential expression patterns in iAs-transformed versus
nontransformed cells. The use of top-down mass spectrom-
etry allowed us to achieve this high level of resolution on the
H2B variants, using another type of analysis would not have
given results conducive to these studies. A combination of
mass spectrometry and qRT-PCR was used to investigate
and validate changes in H2B levels that are induced through
the iAs-mediated transformation. The changes seen in H2B
variants with iAs-mediated transformation suggest that H2B
levels are well regulated and their incorporation into chroma-
tin during this process might be important in the carcinogenic
potential of iAs.
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